Keppra
Product Images NDC 54868-4947

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Keppra (NDC 54868-4947). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle)

FDA Label Image

Principal Display Panel (750 mg Tablet Bottle)

FDA Label Image

Chemical Structure (Keppra 01)

FDA Label Image

Figure (Keppra 02)

Figure (Keppra 02)
This appears to be a chart or table with percentages and medication names, including "Phcebo" and "KEPPRA" at different dosage levels. There are also two entries marked with asterisks. The table may be related to the efficacy of these medications for treating a specific condition in a group of patients, but without additional context it is difficult to determine the exact meaning of the data presented.*
FDA Label Image

Figure (Keppra 03)

FDA Label Image

Figure (Keppra 04)

FDA Label Image

Figure (Keppra 05)

Figure (Keppra 05)
This appears to be a table or graph displaying the percentage of patients who received placebo (7 in total) versus the percentage of patients who received Keppra (101 in total). The first percentage is 19.6% and the second percentage is 44.6%. However, without further context, it is not possible to determine what the percentages refer to (e.g. side effects, efficacy, etc.).*
FDA Label Image

Figure (Keppra 06)

FDA Label Image

Figure (Keppra 07)

Figure (Keppra 07)
The text represents data on the percentage of patients who were part of a study and were administered either a placebo or KEPPRA medication. The percentage of patients who were administered KEPPRA is 72.2%, while the number of patients administered placebo was 84 and KEPPRA was 79.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.